COSO

G&A INSTITUTE ANNOUNCES 2024 PATHFINDER WEBINAR SERIES: Navigating the New Regulatory Environment for Corporate Sustainability Disclosures

Retrieved on: 
Wednesday, March 27, 2024
ERM, Risk management, Accounting, Knowledge, Research, ISSB, G&A, COSO, ICSR, GRI, CSRD, Legislation, JD, CPA, Renewable energy

NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) --  Governance & Accountability Institute, Inc. (G&A), a leader in corporate sustainability consulting and research, is pleased to announce its 2024 Pathfinder Webinar Series.

Key Points: 
  • NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) --  Governance & Accountability Institute, Inc. (G&A), a leader in corporate sustainability consulting and research, is pleased to announce its 2024 Pathfinder Webinar Series.
  • Participants will dive into an ocean of knowledge, with the G&A team and guest experts helping to demystify the shifting tides of sustainability reporting and regulatory compliance.
  • The Pathfinder Webinar Series is designed to inform and empower corporate reporters with the knowledge and tools needed to navigate the increasingly complex landscape of both domestic and international sustainability reporting.
  • G&A invites you to join us on this journey through the new regulatory environment for sustainability disclosures.

G&A Institute Announces 2024 Pathfinder Webinar Series: Navigating the New Regulatory Environment for Corporate Sustainability Disclosures

Retrieved on: 
Wednesday, March 27, 2024
Environment, Climate Change, Environmental Policy, Other Energy, Professional Services, Sustainability, Energy, Environmental, Social and Governance (ESG), Other Professional Services, ERM, Risk management, Accounting, Knowledge, Research, ISSB, G&A, COSO, ICSR, GRI, CSRD, Legislation, JD, CPA, Renewable energy

Governance & Accountability Institute, Inc. (G&A), a leader in corporate sustainability consulting and research, is pleased to announce its 2024 Pathfinder Webinar Series.

Key Points: 
  • Governance & Accountability Institute, Inc. (G&A), a leader in corporate sustainability consulting and research, is pleased to announce its 2024 Pathfinder Webinar Series.
  • Participants will dive into an ocean of knowledge, with the G&A team and guest experts helping to demystify the shifting tides of sustainability reporting and regulatory compliance.
  • The Pathfinder Webinar Series is designed to inform and empower corporate reporters with the knowledge and tools needed to navigate the increasingly complex landscape of both domestic and international sustainability reporting.
  • G&A invites you to join us on this journey through the new regulatory environment for sustainability disclosures.

G&A INSTITUTE ANNOUNCES 2024 PATHFINDER WEBINAR SERIES: Navigating the New Regulatory Environment for Corporate Sustainability Disclosures

Retrieved on: 
Thursday, March 28, 2024
EST, ERM, Risk management, Accounting, Knowledge, Research, ISSB, G&A, COSO, ICSR, GRI, CSRD, Legislation, Context, JD, CPA

NEW YORK, March 28, 2024 /PRNewswire-PRWeb/ -- Governance & Accountability Institute, Inc. (G&A), a leader in corporate sustainability consulting and research, is pleased to announce its 2024 Pathfinder Webinar Series. Registration is now open for the first segment of the series to be held on Wednesday, April 24. Click here to register.

Key Points: 
  • G&A announces its new Pathfinder Webinar Series to help U.S. corporate executives and managers navigate the new regulatory environment for corporate sustainability.
  • Learn more about the topics to be covered and register at https://www.ga-institute.com/webinar/pathfinder-series.html
    NEW YORK, March 28, 2024 /PRNewswire-PRWeb/ -- Governance & Accountability Institute, Inc. (G&A), a leader in corporate sustainability consulting and research, is pleased to announce its 2024 Pathfinder Webinar Series.
  • Participants will dive into an ocean of knowledge, with the G&A team and guest experts helping to demystify the shifting tides of sustainability reporting and regulatory compliance.
  • The G&A team invites you to join us on this enlightening journey through the new regulatory environment for sustainability disclosures.

CoastalSouth Bancshares, Inc. and Coastal States Bank Announce Changes to Boards of Directors

Retrieved on: 
Monday, March 18, 2024
Acquisition, Private equity, HEAD, Bar association, Hospital, Knowledge, LLP, CSB, COSO, University, Doctor of Philosophy, Gee, Partnership, Management

HILTON HEAD ISLAND, S.C., March 18, 2024 /PRNewswire/ -- CoastalSouth Bancshares, Inc. ("COSO") and its wholly-owned subsidiary, Coastal States Bank ("CSB"), announced today that Mr. Ping Lee, PhD is stepping down as a member of their Boards of Directors.

Key Points: 
  • HILTON HEAD ISLAND, S.C., March 18, 2024 /PRNewswire/ -- CoastalSouth Bancshares, Inc. ("COSO") and its wholly-owned subsidiary, Coastal States Bank ("CSB"), announced today that Mr. Ping Lee, PhD is stepping down as a member of their Boards of Directors.
  • "Ping was an excellent representative for former Cornerstone shareholders, as well a strong financial steward for all COSO shareholders."
  • The Boards of Directors of COSO and CSB also announced today that Mr. John G. Aldridge, Jr. ("Gee") has been appointed to serve as a member of both Boards of Directors.
  • "I am very pleased to announce that Gee has joined our Board of Directors," said Stephen Stone, President and CEO of COSO and CSB.

Chemours Provides Update on Internal Review

Retrieved on: 
Thursday, March 7, 2024
Manufacturing, Other Manufacturing, Other Technology, Technology, Chemicals, Plastics, CFO, Collection, Audit, Annual report, COSO, Chemours, Communication, General counsel, Audit committee, Controller, Failure

As previously disclosed, the Audit Committee of the Board of Directors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), with the assistance of independent outside counsel, has been overseeing an internal review.

Key Points: 
  • As previously disclosed, the Audit Committee of the Board of Directors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), with the assistance of independent outside counsel, has been overseeing an internal review.
  • The review relates to an anonymous report made to the Chemours Ethics Hotline regarding the matters described below.
  • A substantially complete report of the findings of the internal review was delivered to the full Board on March 5, 2024.
  • Chair Dawn Farrell said “The Chemours Board of Directors takes these issues very seriously and appreciates the diligent efforts by the Audit Committee, with support from its counsel and Company management, to review these matters.

Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results

Retrieved on: 
Thursday, February 29, 2024
Manufacturing, Other Manufacturing, Other Technology, Technology, Chemicals, Plastics, PwC, Senior, Accounting, Procurement, Annual report, COSO, Digital, Data analysis, Sale, Communication, Interim, Audit committee, Partner, Chairperson, Global Operations, EID, Knowledge, Security (finance), Computer security, Clean technology, Controller, Information technology, Bank statement, CC, Glycolic acid, Management

Ms. Dignam joined Chemours in 2015 and has served as our President – Titanium Technologies since March 2023 and previously served as our President – Advanced Performance Materials from 2021 to 2023.

Key Points: 
  • Ms. Dignam joined Chemours in 2015 and has served as our President – Titanium Technologies since March 2023 and previously served as our President – Advanced Performance Materials from 2021 to 2023.
  • Mr. Abbott previously served as Chemours’ Vice President, Digital and Data Analytics Leader from 2021 to 2023 where he was central to designing digital strategies to accelerate Chemours’ journey to becoming a data-driven organization.
  • Past roles at Chemours included Vice President, Chief Accounting Officer and Controller from 2019 to 2021; and Vice President and Chief Audit Executive from 2017 to 2019.
  • In connection with this delay, the Company will file a Form 12b-25 with the Securities and Exchange Commission.

COSO Names Chair Lucia Wind as its first Executive Director

Retrieved on: 
Wednesday, February 7, 2024
Certified Fraud Examiner, Life, COSO, ERM, Risk assessment, Wind, SOX, Committee, Organization, Audit

NEW YORK, Feb. 7, 2024 /PRNewswire/ -- The Executive Board of the Committee of Sponsoring Organizations of the Treadway Commission (COSO) announced today that COSO Chair Lucia M. Wind has been named as COSO's first-ever full-time Chair and Executive Director, effective December 1, 2023.

Key Points: 
  • First-of-its-kind position reinforces board's commitment to enhance COSO; expand significance for future generations of business professionals
    NEW YORK, Feb. 7, 2024 /PRNewswire/ -- The Executive Board of the Committee of Sponsoring Organizations of the Treadway Commission ( COSO ) announced today that COSO Chair Lucia M. Wind has been named as COSO's first-ever full-time Chair and Executive Director, effective December 1, 2023.
  • Serving as COSO's Chair and Executive Director, Wind will expand on her role leading COSO in fulfilling its mission and - elevating COSO as the authority to help organizations drive improvements across the Committee's key areas of focus.
  • This first-of-its-kind role in COSO solidifies the importance COSO's Executive Board has placed on dedicating resources to taking COSO to the next level and elevating its importance for the future of business.
  • "Lucia has already made great strides for COSO, bringing our mission to life through her deep knowledge, transformative spirit, and forward-thinking vision for the organization," said Doug Prawitt, Ph.D., CPA., Lead Director of COSO.

COSO and NACD Issue Request for Proposal to Develop Corporate Governance Framework and Application Guidance

Retrieved on: 
Wednesday, January 31, 2024
CGF, Knowledge, Future, Risk management, COSO, ERM, NACD, Corporation, Enterprise risk management, RFP, Committee, National Association, Audit

NEW YORK, Jan. 31, 2024 /PRNewswire/ -- The Committee of Sponsoring Organizations of the Treadway Commission ( COSO ), in collaboration with the National Association of Corporate Directors ( NACD ), has issued a Request for Proposal (RFP) to develop a Corporate Governance Framework (CGF).

Key Points: 
  • NEW YORK, Jan. 31, 2024 /PRNewswire/ -- The Committee of Sponsoring Organizations of the Treadway Commission ( COSO ), in collaboration with the National Association of Corporate Directors ( NACD ), has issued a Request for Proposal (RFP) to develop a Corporate Governance Framework (CGF).
  • While other governance frameworks and standards exist worldwide, there is currently no authoritative guidance in the United States.
  • COSO is broadly recognized as an independent and authoritative body in the areas of internal control, risk management, governance, and fraud deterrence.
  • COSO, in collaboration with NACD, strives to develop a CGF, complementing and aligned with the existing COSO Internal Control (IC) and Enterprise Risk Management (ERM) frameworks.

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

Retrieved on: 
Tuesday, January 23, 2024
COSO, Research, Proteomics, Mass spectrometry, Fluid mechanics, Deep learning, Tissue, DIA, Drug discovery, Acquisition, Plasma, Drug development, Acceleration, Cell, Invention, Fine chemical

This US expansion facilitates access to select proteomics contract research organization (CRO) services for our US biopharma customers.

Key Points: 
  • This US expansion facilitates access to select proteomics contract research organization (CRO) services for our US biopharma customers.
  • The Massachusetts facility will initially focus on TrueDiscovery® data-independent acquisition (DIA) discovery proteomics services that offer biopharma researchers high-throughput proteome profiling with industry-leading depth, reproducibility, and cost-efficiency, powered by the Bruker timsTOF mass spectrometry platform.
  • Biognosys also anticipates offering additional discovery and targeted proteomics services for US customers to access domestically in the future.
  • “The opening of our new CRO facility in Massachusetts marks a milestone in our commitment to making proteomics accessible globally for life science research and drug development,” commented Dr. Oliver Rinner, CEO and co-founder of Biognosys.

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

Retrieved on: 
Tuesday, January 23, 2024
Science, Software, Biotechnology, Research, Pharmaceutical, Health, Health Technology, Technology, COSO, Proteomics, Mass spectrometry, Multimedia, GCP, Partnership, Deep learning, Tissue, DIA, Drug discovery, Acquisition, Plasma, Drug development, Acceleration, Proteome, Protein, Cell, Invention, Fine chemical

Biognosys , a leader in next-generation proteomics solutions for drug discovery and development, announced today the operational readiness of its new proteomics facility in Massachusetts.

Key Points: 
  • Biognosys , a leader in next-generation proteomics solutions for drug discovery and development, announced today the operational readiness of its new proteomics facility in Massachusetts.
  • This US expansion facilitates access to select proteomics contract research organization (CRO) services for our US biopharma customers.
  • Biognosys also anticipates offering additional discovery and targeted proteomics services for US customers to access domestically in the future.
  • “The opening of our new CRO facility in Massachusetts marks a milestone in our commitment to making proteomics accessible globally for life science research and drug development,” commented Dr. Oliver Rinner, CEO and co-founder of Biognosys.